Last $95.21 USD
Change Today +1.79 / 1.91%
Volume 861.9K
ALNY On Other Exchanges
Symbol
Exchange
NASDAQ GS
Frankfurt
As of 8:10 PM 01/26/15 All times are local (Market data is delayed by at least 15 minutes).

Insiders at alnylam pharmaceuticals inc (ALNY)

Name (Connections)Board RelationshipsTitleType of Board MemberAge
John Clarke 111 RelationshipsFounder, Chairman, Chairman of Nominating & Corporate Governance Committee and Member of Audit CommitteeTop Key Executive60
John Maraganore M.D., Ph.D.169 RelationshipsChief Executive Officer and Executive DirectorChief Executive Officer51

Other Board Members on Board*

Name (Connections)Board RelationshipsType of Board MemberPrimary CompanyAge
Phillip Sharp Ph.D. 172 RelationshipsMember of the Board of DirectorsAmerican Association for the Advancement of Science69
Kevin Starr 81 RelationshipsMember of the Board of DirectorsThird Rock Ventures, LLC51
Steven Paul M.D. 138 RelationshipsMember of the Board of DirectorsSage Therapeutics, Inc.63
Paul Schimmel Ph.D. 80 RelationshipsMember of the Board of DirectorsMetabolon, Inc.73
Thomas Tuschl Ph.D. 25 RelationshipsMember of Advisory BoardAlnylam Pharmaceuticals, Inc.--
Phillip Zamore Ph.D. 16 RelationshipsMember of Advisory BoardVoyager Therapeutics, Inc.--
Markus Stoffel M.D., Ph.D. 26 RelationshipsMember of Advisory BoardPanCel Corporation--
Robert Langer Jr., Ph.D., Sc.D 447 RelationshipsMember of Advisory BoardInVivo Therapeutics Holdings Corp.66
David Bartel Ph.D. 28 RelationshipsMember of Advisory BoardRegulus Therapeutics Inc.--
Dennis Ausiello M.D. 97 RelationshipsMember of the Board of DirectorsProventys, Inc.68
Judy Lieberman M.D., Ph.D. 24 RelationshipsMember of Advisory BoardAlnylam Pharmaceuticals, Inc.--
Marsha Fanucci 61 RelationshipsMember of the Board of DirectorsMomenta Pharmaceuticals Inc.60
Daniel Rader M.D., FAHA 61 RelationshipsMember of Advisory BoardVascular Strategies LLC--
Amy Schulman J.D. 131 RelationshipsMember of the Board of DirectorsArsia Therapeutics, Inc.53
Michael Bonney B.A. 30 RelationshipsMember of the Board of DirectorsCalixa Therapeutics, Inc.56
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ALNY:US $95.21 USD +1.79

ALNY Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Galena Biopharma Inc $1.72 USD +0.06
Prosensa Holding NV $18.95 USD +0.13
Regulus Therapeutics Inc $19.42 USD +0.88
Silence Therapeutics PLC 226.00 GBp +1.25
Tekmira Pharmaceuticals Corp C$31.80 CAD +0.61
View Industry Companies
 

Industry Analysis

ALNY

Industry Average

Valuation ALNY Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 190.9x
Price/Book 7.9x
Price/Cash Flow NM Not Meaningful
TEV/Sales 189.4x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ALNYLAM PHARMACEUTICALS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.